Features | Partner Sites | Information | LinkXpress
Sign In


Roche Acquires Rights to “Superbug” Antibiotic

Roche Holding has agreed to pay as much as USD 548 million to Polyphor for the rights to an experimental antibiotic that targets drug-resistant Pseudomonas aeruginosa.  More...
11 Nov 2013

Research Grant to Fund Development of Novel Tumor-Imaging Nanoprobes

Research funds have been awarded that will support a collaborative effort to develop novel nanoprobes to be used for in vivo tumor imaging.  More...
04 Nov 2013

Biomarkers Market Expected to Flourish at CAGR 18.5% to 2018

The global biomarkers market demonstrates high growth possibilities and accounts for USD 17.5 billion in 2013. More...
15 Oct 2013
Image: The Intact Modular Filler (IMF) is a fully integrated, automatic filling machine performing all filling activities, including container loading, positioning, filling, and container unloading. The IMF can fill glass or plastic containers of various shapes and sizes (bottles, vials, pouches) with high precision and consistency (Photo courtesy of Medical Instill Technologies).

Partnership to Promote Multiple-Use Filters and Connectors for the Biopharmaceutical Industry

A partnership has been established to promote the utilization of multiple-use sterile filtration and connection devices in the biopharmaceutical industry. More...
30 Sep 2013

Workflow Application Provides Single Cell Analysis for Immunology, Oncology, and Stem Cell Research

NanoString Technologies, a provider of life-science tools for translational research and molecular diagnostic products, and BD Biosciences, reported on a collaboration agreement for the development of a single cell isolation and analysis workflow. More...
17 Sep 2013

Market for MicroRNA Tools and Services Expected to More than Double

Due to the rapid growth in microRNA research, the markets for reagents and instrumentation in this field as well as for miRNA service providers are expected to more than double over the next several years. More...
16 Sep 2013

European Partners Combine to Bring Therapeutic Antibody to Market

Two European biotechnology companies have agreed to collaborate to complete development and commence marketing of a novel therapeutic antibody that targets the GD2 antigen, which is abundantly expressed on neuroblastoma cells. More...
15 Aug 2013

BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
Copyright © 2000-2015 Globetech Media. All rights reserved.